BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2851760)

  • 1. [Pretherapeutic prognostic factors in small cell bronchial cancer].
    Niederle N; Eberhardt W; Hirche H
    Onkologie; 1988; 11 Suppl 2():34-40. PubMed ID: 2851760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with cytostatic treatment of small cell bronchial cancer].
    Wurbs W
    Z Erkr Atmungsorgane; 1990; 174(3):204-14. PubMed ID: 2169145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
    Albain KS; Crowley JJ; LeBlanc M; Livingston RB
    J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early irradiation with radiochemotherapy for limited-stage small cell lung cancer is superior to late irradiation].
    Fietkau R; Sauer R
    Strahlenther Onkol; 2002 Nov; 178(11):585-8. PubMed ID: 12518770
    [No Abstract]   [Full Text] [Related]  

  • 6. Current concepts of small-cell lung cancer.
    Akoun GM; Milleron BJ; Mayaud CM
    Clin Ther; 1986; 8(2):138-43. PubMed ID: 3009017
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined modality therapy for small cell lung cancer.
    Saijo N
    Oncology; 1992; 49 Suppl 1():2-9; discussion 10. PubMed ID: 1323808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of small cell bronchial cancers. Prognostic importance of complete response (1,280 patients). Groupe Petites Cellules].
    Lebeau B; Chastang C; Schuller MP; Thiberville L; Vaylet F; Derenne JP; Caillaud D; Muir JF; Coëtmeur D; Lemarié E
    Presse Med; 1995 Jan; 24(4):217-21. PubMed ID: 7899367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study.
    Christodolou C; Pavlidis N; Samantas E; Fountzilas G; Kouvatseas G; Pagdatoglou K; Palamidas F; Nikolaidis C; Angelidou M; Kalofonos HP; Kosmidis P; Skarlos DV
    Anticancer Res; 2002; 22(6B):3749-57. PubMed ID: 12552988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment for limited-stage small cell lung cancer (LD-SCLC)].
    Takada M; Yana T; Fukuoka M
    Nihon Rinsho; 2002 May; 60 Suppl 5():471-9. PubMed ID: 12101717
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute.
    Chute JP; Venzon DJ; Hankins L; Okunieff P; Frame JN; Ihde DC; Johnson BE
    Mayo Clin Proc; 1997 Oct; 72(10):901-12. PubMed ID: 9379691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive-stage small-cell lung cancer.
    Spira A; Ettinger DS
    Semin Surg Oncol; 2003; 21(3):164-75. PubMed ID: 14508849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study on prognostic factors in young and old lung cancer patients under chemo-radiotherapy].
    Chen TF; Jiang GL; Fu XL; Wang LJ; Qian H; Zhao S
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):692-6. PubMed ID: 15777511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
    Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
    Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small cell lung cancer: state of the art and future perspectives.
    Stupp R; Monnerat C; Turrisi AT; Perry MC; Leyvraz S
    Lung Cancer; 2004 Jul; 45(1):105-17. PubMed ID: 15196740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of small-cell lung cancer.
    Thatcher N; Faivre-Finn C; Lorigan P
    Ann Oncol; 2005; 16 Suppl 2():ii235-9. PubMed ID: 15958464
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
    Kamath SS; McCarley DL; Zlotecki RA
    Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy in bronchial carcinoma].
    Manegold C; Drings P
    Schweiz Med Wochenschr; 1995 Jul; 125(29):1396-405. PubMed ID: 7545824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.
    Cortazar P; Gazdar AF; Woods E; Russell E; Steinberg SM; Williams J; Ihde DC; Johnson BE
    Clin Cancer Res; 1997 May; 3(5):741-7. PubMed ID: 9815744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.